NantKwest(NK)

NantKwest(NK)2020-12-12 05:27

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-062936  Size: 6 KB 网页链接查看全文

NantKwest(NK)2020-12-12 07:36

$NantKwest(NK)$ 内部交易: 2020-12-10,Director,Thomas John C ,卖出,42592普通股, $10.83查看全文

NantKwest(NK)2020-11-10 05:28

$NantKwest(NK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-052488  Act: 34  Size: 12 MB 网页链接查看全文

NantKwest(NK)2020-10-30 04:33

$NantKwest(NK)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-056221  Size: 5 KB 网页链接查看全文

NantKwest(NK)2020-10-27 05:12

$NantKwest(NK)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-20-277062  Act: 34  Size: 31 KB 网页链接查看全文

NantKwest(NK)2020-08-25 04:18

$NantKwest(NK)$ 8-K Current report, item 1.01 Accession Number: 0001193125-20-228341  Act: 34  Size: 19 KB 网页链接查看全文

NantKwest(NK)2020-08-22 04:42

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-047941  Size: 5 KB 网页链接查看全文

NantKwest(NK)2020-08-22 08:45

$NantKwest(NK)$ 内部交易: 2020-08-19,Director,Thomas John C ,卖出,20000普通股, $9.19查看全文

NantKwest(NK)2020-08-14 04:36

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-046606  Size: 9 KB 网页链接查看全文

NantKwest(NK)2020-08-14 08:42

$NantKwest(NK)$ 内部交易: 2020-08-11,Director,Cohen Cheryl ,卖出,30000普通股, $9.96查看全文

合作开发通用实体瘤NK样细胞疗法，新锐B轮融资超5亿

医麦客2023-02-19 07:37

2023年2月19日/医麦客新闻 eMedClub News/--近日，临床阶段公司GAIA BioMedicine宣布和TreeFrog Therapeutics合作，利用TreeFrog 的C-Stem™技术大规模扩增针对实体瘤的同种异体NK样细胞，进而解决NK样细胞的供应难题。早在2021年，TreeFrog Therapeutics完成了7500万美元的B轮融资以推进C-Stem:...查看全文

资本主义拉美行不通2022-05-11 09:16

回复@进雪球做方丈: 制造业占比高的国家，你可以拉个清单看看都是些什么国家。Industry (including construction), value added (% of GDP) | Data (worldbank.org){Industry (including construction), value added (% of GDP) | Data (worldbank.org)}
网页链接查看全文

$NantKwest(NK)$ 8-K Current report, items 2.01, 2.03, 5.02, 5.03, 5.07, 7.01, 8.01, and 9.01 Accession Number: 0001193125-21-075243  Act: 34  Size: 9 MB 网页链接

$NantKwest(NK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-073337  Act: 34  Size: 18 KB 网页链接

$NantKwest(NK)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-21-010945  Act: 34  Size: 24 MB 网页链接

$NantKwest(NK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-065633  Act: 34  Size: 89 KB 网页链接

$NantKwest(NK)$ 8-K Current report, item 8.01 Accession Number: 0001193125-21-057184  Act: 34  Size: 160 KB 网页链接

$NantKwest(NK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-057197  Act: 34  Size: 32 KB 网页链接

$NantKwest(NK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-055176  Act: 34  Size: 30 KB 网页链接

$NantKwest(NK)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-21-054808  Act: 34  Size: 193 KB 网页链接

$NantKwest(NK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-054816  Act: 34  Size: 56 KB 网页链接

$NantKwest(NK)$ 8-K Current report, item 5.02 Accession Number: 0001193125-21-036358  Act: 34  Size: 141 KB 网页链接